source
- GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.BioPharma Dive · 2mo ago↗ source
- CVS obesity drug deal puts Lilly on equal footing with NovoThe agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.BioPharma Dive · 2mo ago↗ source
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) InfectionToday, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarr…